Antisense oligonucleotide-mediated disruption of HTT caspase-6 cleavage site ameliorates the phenotype of YAC128 Huntington disease mice
Neurobiology of Disease · 2024
DOI: 10.1016/j.nbd.2023.106368 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurobiology of Disease, 2024. Verfasst von Elsa C Kuijper und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Genetics, Leiden University Medical Center, the Netherlands. Electronic address: e.c.kuijper@lumc.nl. Hauptthemen laut MEDLINE: Huntington Disease. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
In Huntington disease, cellular toxicity is particularly caused by toxic protein fragments generated from the mutant huntingtin (HTT) protein. By modifying the HTT protein, we aim to reduce proteolytic cleavage and ameliorate the consequences of mutant HTT without lowering total HTT levels. To that end, we use an antisense oligonucleotide (AON) that targets HTT pre-mRNA and induces partial skipping of exon 12, which contains the critical caspase-6 cleavage site. Here, we show that AON-treatment can partially restore the phenotype of YAC128 mice, a mouse model expressing the full-length human HTT gene including 128 CAG-repeats. Wild-type and YAC128 mice were treated intracerebroventricularly with AON12.1, scrambled AON or vehicle starting at 6 months of age and followed up to 12 months of age, when MRI was performed and mice were sacrificed. AON12.1 treatment induced around 40% exon skip and protein modification. The phenotype on body weight and activity, but not rotarod, was restored by AON treatment. Genes differentially expressed in YAC128 striatum changed toward wild-type levels and striatal volume was preserved upon AON12.1 treatment. However, scrambled AON also showed a restorative effect on gene expression and appeared to generally increase brain volume.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Human Genetics, Leiden University Medical Center, the Netherlands. Electronic address: e.c.kuijper@lumc.nl.
- Department of Human Genetics, Leiden University Medical Center, the Netherlands.
- Department of Radiology, Leiden University Medical Center, the Netherlands.
- Université Paris-Saclay, Commissariat à l'Energie Atomique et aux Energies Alternatives, Centre National de la Recherche Scientifique, Molecular Imaging Research Center, Laboratoire des Maladies Neurodégénératives, Fran…
- Department of Biomedical Data Sciences, Leiden University Medical Center, the Netherlands.
- Department of Human Genetics, Leiden University Medical Center, the Netherlands; Department of Radiology, Leiden University Medical Center, the Netherlands.
Zitieren
APA
Kuijper, E. C., Overzier, M., Suidgeest, E., Dzyubachyk, O., Maguin, C., Pérot, J. B., Flament, J., Ariyurek, Y., Mei, H., Buijsen, R. A. M., van der Weerd, L., & van Roon-Mom, W. (2024). Antisense oligonucleotide-mediated disruption of HTT caspase-6 cleavage site ameliorates the phenotype of YAC128 Huntington disease mice. Neurobiology of Disease. https://doi.org/10.1016/j.nbd.2023.106368
Vancouver
Kuijper EC, Overzier M, Suidgeest E, Dzyubachyk O, Maguin C, Pérot JB, et al. Antisense oligonucleotide-mediated disruption of HTT caspase-6 cleavage site ameliorates the phenotype of YAC128 Huntington disease mice. Neurobiology of Disease. 2024. doi:10.1016/j.nbd.2023.106368
BibTeX
@article{Kuijper2024,
author = {Kuijper, Elsa C and Overzier, Maurice and Suidgeest, Ernst and Dzyubachyk, Oleh and Maguin, Cécile and Pérot, Jean-Baptiste and Flament, Julien and Ariyurek, Yavuz and Mei, Hailiang and Buijsen, Ronald A M and van der Weerd, Louise and van Roon-Mom, Willeke},
title = {Antisense oligonucleotide-mediated disruption of HTT caspase-6 cleavage site ameliorates the phenotype of YAC128 Huntington disease mice},
journal = {Neurobiology of Disease},
year = {2024},
doi = {10.1016/j.nbd.2023.106368}
}
EUVIMED